ALDH1A3 and cancer: ALDH1A3 labels an aggressive subtype of human PDAC, and patients with ALDH1A3 expression have shorter survival after surgical resection [58], and inhibition of ALDH1A3 can lead to reduction of cancer cell growth [59].